BioSpace News Archive

Brickell Biotech, Inc., a clinical-stage medical dermatology company, today announced positive results of its confirmatory Phase IIb study of sofpironium bromide for the topical treatment of primary axillary hyperhidrosis, or excessive underarm sweating.

SDL (LSE: SDL) has announced the availability of SDL Multilingual Submission Management (MSM), a web-based platform that enables biopharmaceutical firms to globally automate the submission of multilingual marketing authorization applications to regulatory authorities across 100+ languages and markets.

Invacare Corporation today expanded its healthcare informatics offering via the launch of the enhanced Invacare Platinum Mobile Oxygen Concentrator with Connectivity.

Synlogic, a clinical stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that the FDA has granted Orphan Drug Designation to SYNB1618,

Magellan will promptly submit a response to the Warning Letter for the Agency’s consideration.

Evidera announced the expansion of its patient-centered research services to provide clients with new and innovative approaches to more effectively gather and incorporate patient perspectives into drug development programs.

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials FT. MYERS, FL--(Marketwired - October 24, 2017) - NeoGenomics, Inc. ( NASDAQ : NEO ) , a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened its first international laboratory facility in Rolle, Switzerland, in the Canton of Vaud, just outside of Geneva as a separate subsidiary, NeoGenomics Euro

ABEC announced that Emergent BioSolutions will equip their Baltimore, Maryland bulk manufacturing facility (Bayview), designated a Center for Innovation in Advanced Development and Manufacturing (CIADM), with an ABEC 4,000L CSR bioreactor.

This development effort is being conducted in collaboration with Vical’s strategic partner, AnGes of Osaka, Japan.

Nuvectra will hold a conference call on Wednesday, November 1, 2017 at 4:30pm ET to discuss the results.